J1170
J1170 – Injection, hydromorphone, up to 4 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 39 NDCs crosswalked
📋 J1170 summary
J1170 is a HCPCS Level II J-code used to bill hydromorphone, up to 4 mg. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J1170: Hydromorphone Hydrochloride, Dilaudid
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ1170
DescriptorInjection, hydromorphone, up to 4 mg
Billing unitNot available in current dataset
Payment limit / unit Not available in current dataset
Mapped NDCs39
Data periodNot available in current dataset
Last updatedSource date not available
💊 About Hydromorphone Injection DRUG GUIDE
Hydromorphone Hydrochloride Injection is used to manage severe pain when non-opioid or combination pain relievers have not worked or are not expected to work.
It is given only when the pain is serious enough to require an opioid and when other options are inadequate.Hydromorphone Hydrochloride Injection High Potency Formulation (HPF) is a more concentrated version intended only for patients who are already opioid-tolerant — meaning they are already taking significant daily doses of opioids regularly.
It should not be used in patients who have not built up a tolerance to opioids.
Clinical overview from our editorial drug guide for Hydromorphone Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS
Medicare payment limit / unit
—
Est. ASP / unit
—
Est. after 2% sequester
—
HCPCS dosage
—
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).
Full HCPCS code details (official CMS record)
Long descriptionInjection, hydromorphone, up to 4 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date1997-01-01
Date added1982-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J1170 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J1170 LEAST EXPENSIVE FIRST
39 NDCs map to J1170. Bill units = how many HCPCS units one package represents.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|
| 00641-6151-25 | Hydromorphone Hydrochloride 2 mg/mL INJECTION | Hikma | 25 VIAL, SINGLE-DOSE in 1 CARTON (0641-615... | 2 mg/mL | 0.5 | $2.740 | ● Active | PDAC |
| 63323-0853-25 | Hydromorphone Hydrochloride 2 mg/mL INJECTION, SOLUTION | Fresenius | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-85... | 2 mg/mL | 0.5 | $2.740 | ● Active | PDAC |
| 00409-1312-30 | Hydromorphone Hydrochloride 2 mg/mL INJECTION, SOLUTION | Hospira, | 10 CARTRIDGE in 1 CARTON (0409-1312-30) /... | 2 mg/mL | 0.5 | $3.245 | ● Active | PDAC |
| 00641-6169-10 | Hydromorphone Hydrochloride 1 mg/mL INJECTION | Hikma | 10 SYRINGE in 1 CARTON (0641-6169-10) / 1... | 1 mg/mL | 0.25 | — | ● Active | PDAC |
| 00409-3365-10 | Hydromorphone Hydrochloride 2 mg/mL INJECTION, SOLUTION | Hospira, | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-336... | 2 mg/mL | 0.5 | — | ● Active | PDAC |
| 70092-0532-43 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PF,SULFITE-FREE) 1 MG/1 ML-0.9% | Unknown | — | — | 0.25 | — | — | PDAC |
| 70092-0405-50 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PF,SULFITE-FREE) 0.5 MG/1 ML-0.9% | Unknown | — | — | 0.125 | — | — | PDAC |
| 70092-0293-49 | HYDROMORPHONE HCL-SODIUM CHLORIDE (MONOJECT BARREL,PF) 1 MG/1 ML-0.9% | Unknown | — | — | 0.25 | — | — | PDAC |
| 70092-0290-49 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PF,SULFITE-FREE) 0.5 MG/1 ML-0.9% | Unknown | — | — | 0.125 | — | — | PDAC |
| 70092-0166-48 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PF,SULFITE-FREE) 0.2 MG/1 ML-0.9% | Unknown | — | — | 0.05 | — | — | PDAC |
| 70092-0111-48 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PF,SULFITE-FREE) 0.2 MG/1 ML-0.9% | Unknown | — | — | 0.05 | — | — | PDAC |
| 70092-0112-49 | HYDROMORPHONE HCL-SODIUM CHLORIDE (MONOJECT SYRINGE,PF) 0.2 MG/1 ML-0.9% | Unknown | — | — | 0.05 | — | — | PDAC |
| 70092-0114-50 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PF,SULFITE-FREE) 0.2 MG/1 ML-0.9% | Unknown | — | — | 0.05 | — | — | PDAC |
| 70092-0117-79 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PCA,PF,SULFITE-FREE) 1 MG/1 ML-0.9% | Unknown | — | — | 0.25 | — | — | PDAC |
| 70092-0118-50 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PF,SULFITE-FREE) 1 MG/1 ML-0.9% | Unknown | — | — | 0.25 | — | — | PDAC |
| 00409-1312-36 | Hydromorphone Hydrochloride 2 mg/mL INJECTION, SOLUTION | Hospira, | 10 SYRINGE in 1 CELLO PACK (0409-1312-36)... | 2 mg/mL | 0.5 | — | ● Active | PDAC |
| 00409-1283-37 | Hydromorphone Hydrochloride 1 mg/mL INJECTION, SOLUTION | Hospira, | 10 SYRINGE in 1 CELLO PACK (0409-1283-37)... | 1 mg/mL | 0.25 | — | ● Active | PDAC |
| 70092-0113-79 | HYDROMORPHONE HCL-SODIUM CHLORIDE (PF,SULFITE-FREE) 0.2 MG/1 ML-0.9% | Unknown | — | — | 0.05 | — | — | PDAC |
| 76045-0009-11 | Dilaudid Hydromorphone hydrochloride 1 mg/mL INJECTION, SOLUTION | Fresenius | 10 SYRINGE in 1 CARTON (76045-009-11) / 1... | 1 mg/mL | 0.25 | — | ● Active | PDAC |
| 76045-0010-11 | Dilaudid Hydromorphone hydrochloride 2 mg/mL INJECTION, SOLUTION | Fresenius | 10 SYRINGE in 1 CARTON (76045-010-11) / 1... | 2 mg/mL | 0.5 | — | ● Active | PDAC |
| 00409-3459-07 | HYDROMORPHONE HCL (PF,LATEX-FREE) 2 MG/1 ML | Unknown | — | — | 0.5 | — | — | PDAC |
| 63323-0854-10 | Hydromorphone Hydrochloride 4 mg/mL INJECTION, SOLUTION | Fresenius | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-85... | 4 mg/mL | 1 | — | ● Active | PDAC |
| 63323-0852-25 | Hydromorphone Hydrochloride 1 mg/mL INJECTION, SOLUTION | Fresenius | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-85... | 1 mg/mL | 0.25 | — | ● Active | PDAC |
| 00409-1283-05 | HYDROMORPHONE HYDROCHLORIDE (USP,ISECURE SINGLE-DOSE) 1 MG/ML | Unknown | — | — | 0.25 | — | — | PDAC |
| 00409-1312-10 | HYDROMORPHONE HYDROCHLORIDE (USP,ISECURE SINGLE-DOSE) 2 MG/ML | Unknown | — | — | 0.5 | — | — | PDAC |
| 00409-1283-10 | HYDROMORPHONE HYDROCHLORIDE (USP,ISECURE SINGLE-DOSE) 1 MG/ML | Unknown | — | — | 0.25 | — | — | PDAC |
| 00409-3365-01 | HYDROMORPHONE HCL (SDV,25X1ML) 2 MG/ML | Unknown | — | — | 0.5 | — | — | PDAC |
| 00409-3356-01 | HYDROMORPHONE HCL (10X1ML,USP) 2 MG/ML | Unknown | — | — | 0.5 | — | — | PDAC |
| 00409-2552-01 | HYDROMORPHONE HCL (USP,10X1ML) 1 MG/ML | Unknown | — | — | 0.25 | — | — | PDAC |
| 00409-2540-01 | HYDROMORPHONE HCL (USP,10X1ML) 4 MG/ML | Unknown | — | — | 1 | — | — | PDAC |
| 00409-1304-31 | Hydromorphone Hydrochloride 4 mg/mL INJECTION, SOLUTION | Hospira, | 10 CARTRIDGE in 1 CARTON (0409-1304-31) /... | 4 mg/mL | 1 | — | ● Active | PDAC |
| 00409-1283-31 | Hydromorphone Hydrochloride 1 mg/mL INJECTION, SOLUTION | Hospira, | 10 CARTRIDGE in 1 CARTON (0409-1283-31) /... | 1 mg/mL | 0.25 | — | ● Active | PDAC |
| 63275-2100-09 | HYDROMORPHONE HCL (U.S.P.) | Unknown | — | — | 250 | — | — | PDAC |
| 63275-2100-05 | HYDROMORPHONE HCL (U.S.P.) | Unknown | — | — | 250 | — | — | PDAC |
| 63275-2010-03 | HYDROMORPHONE HCL (U.S.P.) | Unknown | — | — | 250 | — | — | PDAC |
| 63275-2005-02 | HYDROMORPHONE HCL (U.S.P.) | Unknown | — | — | 250 | — | — | PDAC |
| 63275-2001-01 | HYDROMORPHONE HCL (U.S.P.) | Unknown | — | — | 250 | — | — | PDAC |
| 00641-2341-41 | Hydromorphone Hydrochloride 2 mg/mL INJECTION | Hikma | 20 VIAL in 1 CARTON (0641-2341-41) / 20 m... | 2 mg/mL | 0.5 | — | ● Active | PDAC |
| 00641-0121-25 | HYDROMORPHONE HCL (VIAL, DOSETTE) 2 MG/ML | Unknown | — | — | 0.5 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
🗺️ Where J1170 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 82,391 services across 19 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J1170
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Not available
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
39 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J1170 billing FAQ
What is HCPCS code J1170?
J1170 is a HCPCS Level II J-code used to bill Injection, hydromorphone, up to 4 mg under Medicare Part B and most medical (not pharmacy) benefits.
Which NDCs bill under J1170?
39 NDCs currently map to J1170 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J1170 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.